B-VEC Shows Quality of Life Improvements in Dystrophic Epidermolysis Bullosa
Krystal Biotech's investigational topical gene therapy has shown promise in DEB. It is designed to deliver COL7A1 and restore C7 protein in patients with the rare disorder.